NEW YORK, July 18 – Third Wave Agbio said Wednesday that Valigen has agreed to use its Invader SNP analysis platform to study genetic variations in plants.
As part of its research into developing agricultural products with improved traits, Valigen, headquartered in Paris-la-Defense, France, will use Third Wave Agbio’s technology to detect genetic changes in plants modified using Valigen’s Genoplasty technology.
Financial details of the deal were not disclosed.
The Genoplasty technology allows Valigen to introduce an oligonucleotide into a target cell, and use the cell’s mechanism for DNA repair to modify its genetic sequence according to the sequence of the oligonucleotide.
Third Wave Technologies, based in Madison, Wisc., is a significant stakeholder in Third Wave Agbio, also of Madison.